Cure

Oyate Group Celebrates Three Years of Community Leadership with Expansion of Community-Based Programs and Staff

Retrieved on: 
Jeudi, juin 15, 2023
Learning, Poverty, City College of New York, Small business, Food, Housing, Fordham University, Violence, Education, Lehman College, Culture, Curriculum, COVID-19, International Film Awards Berlin, Cure, Oyate, Public housing, Mentorship, Vaccine hesitancy, Firearm, School, New Yorker, Social justice, City & State, BIPOC, Community capitalism, Nightclub, Management, The Bronx

NEW YORK, June 15, 2023 /PRNewswire-PRWeb/ -- Oyate Group, a nonprofit organization on a mission to alleviate poverty by creating sustainable and holistic solutions that empower underserved communities all across New York City, is celebrating three years of service to The Bronx, Harlem, Washington Heights and Brooklyn by expanding its community and youth development programs with the help of two new team members and community leaders, Augustina Warton and Alex Reyes.

Key Points: 
  • They bring a level of passion, civic engagement and experience that will create strides for the organization and bolster our programs across New York City's boroughs.
  • Alex Reyes, a community organizer, leader and advocate for affordable housing and a path to citizenship for undocumented families, will serve Oyate Group as its program coordinator.
  • Three years on, Oyate Group is now expanding its Beyond Rising Internship Program and Brandon Hendricks Scholarship .
  • Media interested in learning more about Oyate Group and its programs should contact Emiliano Garcia at mailto: [email protected] [email protected] or (917) 446-7571.

Immune-Onc Therapeutics Presents IO-202 Phase 1 Data in Patients with Relapsed or Refractory AML and CMML at the EHA Annual Meeting 2023

Retrieved on: 
Jeudi, juin 8, 2023
Oncology, Health, FDA, General Health, Clinical Trials, Pharmaceutical, Biotechnology, CMML, AZA, Myelocyte, PD, European Hematology Association, LILRB4, Associate professor, ILT3, Acute leukemia, Chronic myelomonocytic leukemia, Bone marrow, Pharmacokinetics, Fast track (FDA), Acute myeloid leukemia, MD Anderson Cancer Center, MSCE, AML, Azacitidine, Monocyte, Pancreatic serous cystadenoma, MD, Patient, Immunoglobulin G, Division, University, Cure, Blood, EHA, Toxic leukoencephalopathy, Leukemia, Therapy, Safety, Vaccine, Pharmaceutical industry, Rare-earth element

Data from the dose escalation part of the Phase 1 study evaluating patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) and chronic myelomonocytic leukemia (CMML) will be presented during a poster session at the European Hematology Association (EHA) Annual Meeting in Frankfurt, Germany on June 9, 2023.

Key Points: 
  • Data from the dose escalation part of the Phase 1 study evaluating patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) and chronic myelomonocytic leukemia (CMML) will be presented during a poster session at the European Hematology Association (EHA) Annual Meeting in Frankfurt, Germany on June 9, 2023.
  • “AML is the most common form of acute leukemia in adults in the U.S. and is characterized by high rates of relapsed and refractory disease.
  • Monocytic AML is especially in need of break-through medicine as it is often resistant to standard-of-care treatment.
  • Poster presentation details are as follows:
    Title: A first-in-human Phase 1 study of IO-202 (anti-LILRB4 mAb) in Acute Myeloid Leukemia (AML) with monocytic differentiations and Chronic Myelomonocytic Leukemia (CMML) patients.

ZERO Prostate Cancer Taps Breast Cancer Leader and Survivor as Next President and CEO

Retrieved on: 
Jeudi, juin 8, 2023
Race, Komen, Prostate cancer, Health equity, Cancer, Hope, Cure, Research, ZERO, Young Survival Coalition, Marketing, THAN, Susan, Risk, National Directorate of Intelligence and Prevention Services, Bugle, Growth, CFRE, Certified Funds, Disease, Breast cancer, Management

WASHINGTON, June 8, 2023 /PRNewswire/ -- After a nationwide executive search, ZERO Prostate Cancer proudly announces Courtney Bugler, CFRE, as its new President and CEO, effective August 7. Bugler, a trailblazing nonprofit leader with extensive executive experience in national health nonprofits, fundraising, and advocacy, will succeed the current President and CEO, Jamie Bearse, as part of a planned transition.

Key Points: 
  • WASHINGTON, June 8, 2023 /PRNewswire/ -- After a nationwide executive search, ZERO Prostate Cancer proudly announces Courtney Bugler, CFRE, as its new President and CEO, effective August 7.
  • Bugler, a trailblazing nonprofit leader with extensive executive experience in national health nonprofits, fundraising, and advocacy, will succeed the current President and CEO, Jamie Bearse, as part of a planned transition .
  • Under Bearse's leadership, ZERO Prostate Cancer grew into a premier, nationally-recognized nonprofit, making significant strides in patient support, awareness, and research.
  • "The selection of Courtney Bugler as our new President and CEO represents anexciting chapter in our evolution of ZERO Prostate Cancer.

Builders FirstSource Raises Over $1.2 Million at its Swing for the Cure Golf Charity Event for The Leukemia & Lymphoma Society

Retrieved on: 
Lundi, juin 5, 2023
Interior Design, Health, Residential Building & Real Estate, Construction & Property, Oncology, Georgia-Pacific, B-cell lymphoma, Patient, Four Seasons Resort and Club Dallas at Las Colinas, Interfor, Leukemia, NYSE, Knauf Insulation, NFL, Face, ODL, Bone marrow, Research, Meritage Homes Corporation, LLS, Cornerstone, Philosophy, Leukemia & Lymphoma Society, Audio, Accenture, Survivor, DuPont, JELD-WEN, Firstsource, Humble Oil, Builder, Builders FirstSource, Boise Cascade, Trex, ESPN, Partnership, MI, Pella, Cure, LP, Pharmaceutical industry, Canfor, Masonite

Builders FirstSource, Inc. (NYSE: BLDR) (“Builders FirstSource” or the "Company"), the nation’s largest supplier of building products, prefabricated components, and value-added services to the professional market for new residential construction and repair and remodeling, announced today that its annual Swing for the Cure golf charity event raised more than $1.2 million for The Leukemia & Lymphoma Society (LLS).

Key Points: 
  • Builders FirstSource, Inc. (NYSE: BLDR) (“Builders FirstSource” or the "Company"), the nation’s largest supplier of building products, prefabricated components, and value-added services to the professional market for new residential construction and repair and remodeling, announced today that its annual Swing for the Cure golf charity event raised more than $1.2 million for The Leukemia & Lymphoma Society (LLS).
  • "We are humbled and grateful for the overwhelming support shown by our customers and suppliers in helping us surpass the $1 million mark,” said Dave Rush, CEO of Builders FirstSource.
  • The event featured former NFL star, cancer survivor, best-selling author, and ESPN analyst Merril Hoge as its keynote speaker.
  • "With the continued support and generosity of Builders FirstSource and its partners, we can work towards achieving a world without blood cancer.

National Pediatric Cancer Foundation Collaborates with First Watch to Make Cancer Warrior's Dream Come True

Retrieved on: 
Vendredi, juin 2, 2023
ER, CT, Senior, Neoplasm, Cancer, Cure, Research, Government, First Watch, Cooking, Optic nerve, Birth control, Dentistry

TAMPA, Fla., June 2, 2023 /PRNewswire/ -- The National Pediatric Cancer Foundation (NPCF) partnered with First Watch to provide a dream opportunity for Sophia, a ten-year-old cancer warrior who wants to be a Chef when she grows up!

Key Points: 
  • TAMPA, Fla., June 2, 2023 /PRNewswire/ -- The National Pediatric Cancer Foundation (NPCF) partnered with First Watch to provide a dream opportunity for Sophia, a ten-year-old cancer warrior who wants to be a Chef when she grows up!
  • "First Watch is proud to help make Sophia's dream of being a professional chef come true," said Schaibly.
  • "We are grateful for First Watch and Shane Schaibly for helping us make Sophia's dream come true.
  • The US government only spends 4% of the millions of dollars devoted to cancer research on pediatric cancer research.

CURE HOSTS "AI FOR GOOD" SUPER SESSION TO MAKE SENSE OF BIG DATA AND HIGH TECH AT 2023 BIO INTERNATIONAL CONVENTION ON JUNE 5

Retrieved on: 
Vendredi, juin 2, 2023
BIO, BCH, Road, Super Session, Exhibition, MB, Disease, Biotechnology, Huntington Avenue, Brigham and Women's Hospital, Health, Boston Convention and Exhibition Center, Research, Doctor of Philosophy, Michigan Biotechnology Institute, EDT, Harvard Medical School, BCEC, BAO, Pandemic, MD, JD, ABC, Coffee, Convention center, Neurology, ESG, Digital, Foreign policy, Ecosystem, AI, Alzheimer's disease, Hospital, Woman, WIB, Pharmaceutical industry, Organon, Cure

NEW YORK, June 2, 2023 /PRNewswire/ -- Cure®, a healthcare innovation campus in New York City, today announced a one-of-a-kind Super Session featuring experts focused on leveraging AI for good as part of the company's presence at the Biotechnology International Convention, the largest global event for the biotech industry, in Boston, MA. from June 5 to 8, 2023.

Key Points: 
  • "The dizzying array of things AI can seemingly do – good, great, and worrisome – has the world of healthcare both excited and overwhelmed.
  • For the BIO Super Session, the panel Cure has gathered will discuss how we can optimally leverage AI and other advanced technologies while mitigating risks," said Cure Chief Executive Officer Seema Kumar.
  • The Cure booth also will host Cure Studios on the Road, capturing highlights and insights from leading biotech executives.
  • The booth will be open 8:00 am to 5:00 pm EDT in the BCEC Ground Level Halls A-C from June 5 to 8, 2023.

HeyGears Launches First Professional Desktop 3D Printer for Consumers

Retrieved on: 
Vendredi, juin 2, 2023
Life, Printing, 3D, Reflex, Ultracraft Calypso, Cure, Temperature, Sale, Creativity, NFC, Algorithm, 3D printing, Wash

IRVINE, Calif., June 2, 2023 /PRNewswire/ -- HeyGears, a leading provider of 3D printing technology and solutions, has announced the global launch of pre-sales for its first desktop 3D printing solution available for consumers, the UltraCraft Reflex.

Key Points: 
  • IRVINE, Calif., June 2, 2023 /PRNewswire/ -- HeyGears, a leading provider of 3D printing technology and solutions, has announced the global launch of pre-sales for its first desktop 3D printing solution available for consumers, the UltraCraft Reflex.
  • The limited offer pre-sale price for a Reflex 3D printer is set at US$979.30.
  • The launch of the Reflex is part of HeyGears' commitment to the industry as a pioneer in applying industrial-grade 3D printing technology to professional desktop solutions.
  • The Reflex's comprehensive 3D printing system includes pre-processing software, a printer, a cleaning machine, a curing machine, and HeyGears' self-developed materials.

HeyGears Launches First Professional Desktop 3D Printer for Consumers

Retrieved on: 
Vendredi, juin 2, 2023
Life, Printing, 3D, Reflex, Ultracraft Calypso, Cure, Temperature, Sale, Creativity, NFC, Algorithm, 3D printing, Wash

IRVINE, Calif., June 1, 2023 /PRNewswire/ -- HeyGears, a leading provider of 3D printing technology and solutions, has announced the global launch of pre-sales for its first desktop 3D printing solution available for consumers, the UltraCraft Reflex.

Key Points: 
  • IRVINE, Calif., June 1, 2023 /PRNewswire/ -- HeyGears, a leading provider of 3D printing technology and solutions, has announced the global launch of pre-sales for its first desktop 3D printing solution available for consumers, the UltraCraft Reflex.
  • The limited offer pre-sale price for a Reflex 3D printer is set at US$979.30.
  • The launch of the Reflex is part of HeyGears' commitment to the industry as a pioneer in applying industrial-grade 3D printing technology to professional desktop solutions.
  • The Reflex's comprehensive 3D printing system includes pre-processing software, a printer, a cleaning machine, a curing machine, and HeyGears' self-developed materials.

Cure®, Life Science Cares New York and Science in the City Inc. Partner to Launch Life Sciences Immersion Program for New York City High School Students

Retrieved on: 
Vendredi, juin 2, 2023
Workforce, Entrepreneurship, Poverty, San Francisco Bay Area, Partnership, Drug development, Q&A, Marketing, Biotechnology, Fassberg, National Center for Advancing Translational Sciences, Hope, Pharmacy, EDC, Weill Cornell Medicine, Organization, Student, City, Economic development, NYCEDC, Ecosystem, Therapy, Tourism, Management, Science, Cure, STEM

NEW YORK, June 2, 2023 /PRNewswire/ -- Cure® , a healthcare innovation campus in New York City, today announced a partnership with Life Science Cares New York, Science In the City Inc. with sponsorship from New York Economic Development Corporation  to launch an immersive educational program for New York City high school students interested in life sciences and biotechnology.

Key Points: 
  • NEW YORK, June 2, 2023 /PRNewswire/ -- Cure® , a healthcare innovation campus in New York City, today announced a partnership with Life Science Cares New York, Science In the City Inc. with sponsorship from New York Economic Development Corporation  to launch an immersive educational program for New York City high school students interested in life sciences and biotechnology.
  • The program will bring 50 students from New York City to the Cure campus to learn from scientists and business leaders through a panel event and interactive workshop session.
  • The company currently operates in five cities, including Boston, Philadelphia San Diego, the Bay Area, and most recently, New York City, which launched in November 2022.
  • "The life sciences and biotechnology industries are essential to the city's economic development," said New York City Economic Development Corporation (NYCEDC) President & CEO Andrew Kimball.

Global Genes announces partnership with CureJM Foundation to expand support in rare disease community for mental health related challenges

Retrieved on: 
Jeudi, mai 11, 2023
Partnership, Depression, Anxiety, Mental health, Cure, Mental, Organization, Global Genes, Patient, Research, Health, Disease, Nursing

ALISO VIEJO, Calif., May 11, 2023 /PRNewswire-PRWeb/ -- The rare disease patient advocacy organization Global Genes has partnered with Cure JM Foundation to work together on a two-year mental health initiative.

Key Points: 
  • The rare disease patient advocacy organization Global Genes has partnered with Cure JM Foundation to work together on a two-year mental health initiative.
  • ALISO VIEJO, Calif., May 11, 2023 /PRNewswire-PRWeb/ -- The rare disease patient advocacy organization Global Genes has partnered with Cure JM Foundation to work together on a two-year mental health initiative.
  • Global Genes is committed to improving the health and mental well-being of the rare disease community that it serves.
  • "Mental health is an often-neglected aspect of living with a rare disease," said Charlene Son Rigby, CEO of Global Genes.